Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Elizabeth A. Holland
Based on 12 articles published since 2008
||||
Expertise Level
The expertise of Elizabeth A. Holland ranks in the
  • Top 3.2%
  • ... of 107,286 published authors worldwide on Melanoma
  • ... from 2008 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Holland, E A   ·   Holland, Elizabeth A
Work Locations
Details
Most likely:    University of Sydney      
2017
  • MGH Analytic and Translational Genetics Unit, MGH and Broad Institute, Boston, MA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA. · 1st Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Retina Service, Massachusetts Eye and Ear Infirmary, Boston, MA. · Department of Dermatology, Wellman Center for Photomedicine, MGH, Boston, MA. · Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico. · Melanoma Genetics Program, MGH Cancer Center, MGH, Boston, MA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, Australia. · Melanoma Institute Australia, University of Sydney, North Sydney, NSW, Australia. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. · Pubmed 29522175
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2012
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
Probable:    Mater Hospital      
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Probable:    Westmead Hospital      
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Elizabeth A. Holland about Melanoma:

  • Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. 2017
  • Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. 2016
  • Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. 2015
  • MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. 2013
  • MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study. 2012
  • A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. 2011
  • Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. 2011
  • Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. 2011
  • Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. 2010
  • Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. 2009
Show List of Full Article Records
Google Searches

Learn more about Elizabeth A. Holland using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Sydney
Mater Hospital
Westmead Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Sydney
2017
  • MGH Analytic and Translational Genetics Unit, MGH and Broad Institute, Boston, MA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA. · 1st Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Retina Service, Massachusetts Eye and Ear Infirmary, Boston, MA. · Department of Dermatology, Wellman Center for Photomedicine, MGH, Boston, MA. · Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, Mexico. · Melanoma Genetics Program, MGH Cancer Center, MGH, Boston, MA. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Westmead, Australia. · Melanoma Institute Australia, University of Sydney, North Sydney, NSW, Australia. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. · Pubmed 29522175
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
2012
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
Mater Hospital
2016
  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. · Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin et Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Internal Medicine and Medical Specialties, University of Genoa and IRCCS AOU San Martino-IST Genoa, Italy. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Biopathology and INSERM U1186, Gustave Roussy, Villejuif, France. · Dermatology Unit, Maurizio Bufalini Hospital, Cesena, Italy. · Division of Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Melanoma Unit, Dermatology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain and CIBER de Enfermedades Raras, Barcelona, Spain. · Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia. · INSERM, UMR-946, Genetic Variation and Human Disease Unit, Université Paris Diderot, Paris, France. · Departments of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Department of Clinical Genetics, University Hospital of Copenhagen, Copenhagen, Denmark. · Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. · Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre RS, Brazil. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Institute of Oncology Ljubljana, Zaloska, Ljubljana, Slovenia. · Centre for Cancer Research, Westmead Institute for Medical Research and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Department of Surgery, Lund University Hospital, Lund, Sweden. · Department of Pathology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Oregon Health Sciences University School of Medicine, Department of Dermatology, Portland, Oregon, USA. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. Electronic address: · Pubmed 26827760
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
Westmead Hospital
2015
  • Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH) · Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA) · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG) · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB) · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB) · Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO) · Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ) · Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG) · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ) · Translational Genomics Institute, Phoenix, AZ (JMT) · University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM) · Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM). · Pubmed 25505254
7 Other Locations Show
Yearly article counts 001110113112
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.